SCHEMBL9818643

SCHEMBL9818643

Cc1cccc(NC(=O)NCC2(c3ccccc3)CCCCC2)c1

nearest known ligand 0.60

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.56
CNR1 P21554 1/20 0.55
SMN1; SMN2 Q16637 2/20 0.54
NPC1 O15118 1/20 0.54
RAB9A P51151 1/20 0.54
TP53 P04637 1/20 0.54
LMNA P02545 2/20 0.53
KMT2A Q03164 2/20 0.53
KCNH2 Q12809 1/20 0.53
CACNA1I Q9P0X4 1/20 0.53
NPSR1 Q6W5P4 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
MEN1 O00255 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9818668 0.87 CNR1 (0.70) CNR1SMN1; SMN2TP53LMNAKMT2A
SCHEMBL9818621 0.86 CNR1 (0.66) MAPTCNR1SMN1; SMN2NPC1RAB9A
SCHEMBL300331 0.86 CNR1 (0.72) CNR1SMN1; SMN2TP53LMNAKMT2A
SCHEMBL9818712 0.85 ALDH1A1 (0.69) MAPTSMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL9818698 0.82 MAPT (0.59) MAPTCNR1RAB9ATP53LMNA
SCHEMBL9818742 0.82 TP53 (0.62) MAPTCNR1SMN1; SMN2TP53LMNA
SCHEMBL9818726 0.82 TP53 (0.62) MAPTSMN1; SMN2TP53LMNAKMT2A
SCHEMBL9641050 0.81 TP53 (0.64) MAPTCNR1SMN1; SMN2TP53LMNA
SCHEMBL9818656 0.81 MAPT (0.65) MAPTCNR1SMN1; SMN2NPC1RAB9A
SCHEMBL9640397 0.80 TP53 (0.65) MAPTCNR1SMN1; SMN2TP53LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5015644-A Antihyperlipidemic and antiatherosclerotic urea and carbamate compounds WARNER-LAMBERT COMPANY (US) 1991-05-14 US disclosed